Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
REVENUE	$ 117,640		$ 220,060
Cost of revenue	27,504		84,422
NET REVENUE	90,136		135,638
EXPENSES
General and administrative expenses [Notes 7, 8 and 9]	1,861,113	1,717,666	6,015,942	3,825,602
Research and development expenses	401,271	377,924	889,201	1,106,658
TOTAL OPERATING EXPENSES	2,262,384	2,095,590	6,905,143	4,932,260
Accretion expense [Note 5]				879,416
Change in fair value of derivative liabilities [Note 6]				(20,588)
NET LOSS BEFORE INCOME TAXES	(2,172,248)	(2,095,590)	(6,769,505)	(5,832,264)
Income taxes
NET LOSS	(2,172,248)	(2,095,590)	(6,769,505)	(5,832,264)
Translation adjustment	222,217	(23,424)	232,434	(193,771)
COMPREHENSIVE LOSS	$ (1,950,031)	$ (2,119,014)	$ (6,537,071)	$ (6,026,035)
LOSS PER SHARE, BASIC AND DILUTED	$ (0.064)	$ (0.068)	$ (0.206)	$ (0.186)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING	33,892,765	30,799,342	32,884,003	31,374,911